Lipoprotein(a) in cardiovascular diseases (Q21284797)

19 November 2019

myocardial infarction

1 reference

19 November 2019

1 reference

19 November 2019

1 reference

9

Fabio Galvano

Fabio

Galvano

1 reference

19 August 2022

Giulia Malaguarnera

4

Giulia

Malaguarnera

1 reference

19 August 2022

10

Alessandro

Frigiola

Alessandro Frigiola

1 reference

19 August 2022

Michele Malaguarnera

1

Michele

Malaguarnera

1 reference

19 August 2022

Marco Vacante

2

Marco

Vacante

1 reference

19 August 2022

Cristina Russo

3

Cristina

Russo

1 reference

19 August 2022

Tijana Antic

5

Tijana

Antic

1 reference

19 August 2022

Lucia Malaguarnera

6

Lucia

Malaguarnera

1 reference

19 August 2022

Rita Bella

7

Rita

Bella

1 reference

19 August 2022

Giovanni Pennisi

8

Giovanni

BioMed Research International

Pennisi

1 reference

19 August 2022

language of work or name

English

0 references

publication date

2013

0 references

30 December 2012

6 references

14 March 2019

19 March 2019

22 March 2019

25 April 2019

17 June 2019

19 November 2019

7 references

14 March 2019

19 March 2019

22 March 2019

25 April 2019

17 June 2019

19 November 2019

2013

0 references

page(s)

650989

0 references

copyright license

Creative Commons Attribution 3.0 Unported

6 references

14 March 2019

19 March 2019

22 March 2019

25 April 2019

17 June 2019

on focus list of Wikimedia project

19 November 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Lipoprotein(a) as a cardiovascular risk factor: current status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Apolipoprotein(a) isoforms and coronary heart disease in men: a nested case-control study

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Inflammation in atherosclerosis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lipoprotein(a): Cellular Effects and Molecular Mechanisms

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lipoprotein(a): more interesting than ever after 50 years

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

The physiopathology of lipoprotein (a).

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Inflammatory Reactions in the Pathogenesis of Atherosclerosis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lipoprotein (a) and stroke

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Atherosclerosis is an inflammatory disease

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Serum lipoprotein(a) concentrations are related to coronary disease progression without new myocardial infarction

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Apolipoproteins: pathophysiology and clinical implications

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

A prospective study of lipoprotein(a) and the risk of myocardial infarction

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Structural basis for the presumptive atherothrombogenic action of lipoprotein(a). Facts and speculations

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lipoprotein (a): implication in atherothrombosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lipoprotein Lp(a) excess and coronary heart disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

High plasma levels of apo(a) fragments in Caucasians and African-Americans with end-stage renal disease: implications for plasma Lp(a) assay.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Pathophysiological implication of the structural domains of lipoprotein(a).

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Feedback mechanism of focal vascular lesion formation in transgenic apolipoprotein(a) mice

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Atherogenesis in transgenic mice expressing human apolipoprotein(a)

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Probucol protects lipoprotein (a) against oxidative modification

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Effect of L-carnitine on the size of low-density lipoprotein particles in type 2 diabetes mellitus patients treated with simvastatin.

30 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

The significance of apolipoprotein-B (Apo-B) in the elderly as a predictive factor of cardio-cerebrovascular complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

Urinary excretion of apo(a) in patients after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

Association of serum oxidized lipoprotein(a) concentration with coronary artery disease: potential role of oxidized lipoprotein(a) in the vasucular wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

Lipoprotein(a) enhances advanced atherosclerosis and vascular calcification in WHHL transgenic rabbits expressing human apolipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

Mitogenic activity of oxidized lipoprotein (a) on human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

The apolipoprotein(a) component of lipoprotein(a) stimulates actin stress fiber formation and loss of cell-cell contact in cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

Lipoprotein(a) and cholesterol levels act synergistically and apolipoprotein A-I is protective for the incidence of primary acute myocardial infarction in middle-aged males. An incident case-control study from Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: evidence from the prospective study of pravastatin in the elderly at risk (PROSPER).

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

Urinary Excretion of Apo(a) Fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F650989

A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in women

21 January 2018

2 references

https://api.crossref.org/works/10.1155%2F2013%2F650989

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lipoprotein(a) as a potent risk indicator for early cardiovascular disease

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Enhanced atherosclerosis in Lp(a) WHHL transgenic rabbits.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lipoprotein (a) behaviour in patients with hepatocellular carcinoma

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Serum lipoprotein(a) changes in acute myocardial infarction

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Abnormalities of vascular compliance in hypertension, aging and heart failure

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3591100

Lipoprotein (a) as a risk factor for atherosclerotic diseases

29 November 2018

1 reference

12 December 2020

Proliferation of human smooth muscle cells promoted by lipoprotein(a)

1 reference

12 December 2020

Lipoprotein(a) in the arterial wall

1 reference

12 December 2020

Expression of adhesion molecules by lp(a): a potential novel mechanism for its atherogenicity

1 reference

12 December 2020

Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a)

1 reference

12 December 2020

Predictors of adverse long-term outcome in acute myocardial infarction patients undergoing primary percutaneous transluminal coronary angioplasty: with special reference to the admission concentration of lipoprotein (a)

1 reference

12 December 2020

Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins

1 reference

12 December 2020

The inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1. The effects of fibrinogen, heparin, vitronectin, and lipoprotein(a)

1 reference

12 December 2020

Lipid profile variations in a group of healthy elderly and centenarians

1 reference

12 December 2020

Serum lipoprotein(a) level and clinical coronary stenosis progression in patients with myocardial infarction: re-revascularization rate is high in patients with high-Lp(a)

1 reference

12 December 2020

CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells

1 reference

12 December 2020

Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men

1 reference

12 December 2020

Apo(a) isoforms predict risk for coronary heart disease. A study in six populations

1 reference

12 December 2020

Induction of oxygen free radical generation in human monocytes by lipoprotein(a)

1 reference

12 December 2020

Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients

1 reference

12 December 2020

Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study

1 reference

12 December 2020

Susceptibility of low-density lipoproteins to oxidation in coronary bypass patients

1 reference

12 December 2020

Elevated lipoprotein(a) levels and small apo(a) isoforms are compatible with longevity: evidence from a large population of French centenarians

1 reference

12 December 2020

Apolipoproteins and ischaemic heart disease: implications for screening

1 reference

12 December 2020

Oxidized lipoprotein(a) enhanced the expression of P-selectin in cultured human umbilical vein endothelial cells

1 reference

12 December 2020

Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

1 reference

12 December 2020

Vascular risk factors correlate to the extent as well as the severity of coronary atherosclerosis

1 reference

12 December 2020

Associations between serum lipoprotein(a) levels and the severity of coronary and aortic atherosclerosis

1 reference

12 December 2020

Lipoprotein(a) levels in centenarians

1 reference

12 December 2020

In vivo fate and scavenger receptor recognition of oxidized lipoprotein[a] isoforms in rats

1 reference

12 December 2020

Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies

1 reference

12 December 2020

Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. II. Preferential immobilization of lipoprotein (a) (Lp(a))

1 reference

12 December 2020

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study

1 reference

12 December 2020

Apolipoprotein(a) is present in urine and its excretion is decreased in patients with renal failure

1 reference

12 December 2020

Elevated plasma lipoprotein(a) is associated with coronary artery disease in patients with chronic stable angina pectoris

1 reference

12 December 2020

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

1 reference

12 December 2020

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial

1 reference

12 December 2020

Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macropha

1 reference

12 December 2020

A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study

1 reference

12 December 2020

Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study

1 reference

12 December 2020

Lipoprotein(a). A unique risk factor for atherothrombotic disease

1 reference

12 December 2020

Non-enzymatic glycation of lipoprotein(a) in vitro and in vivo

1 reference

12 December 2020

Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a)

1 reference

12 December 2020

Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium

1 reference

12 December 2020

Euglobulin clot lysis induced by tissue type plasminogen activator in subjects with increased levels and different isoforms of lipoprotein (a).

1 reference

12 December 2020

Apolipoprotein(a) is a human vascular endothelial cell agonist: studies on the induction in endothelial cells of monocyte chemotactic factor activity

1 reference

12 December 2020

Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells

1 reference

12 December 2020